D.E. Shaw & Co
HOOK

D.E. Shaw & Co’s HOOKIPA Pharma HOOK Stock Holding History

D.E. Shaw & Co’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,906
Closed -$89K – 5509
2022
Q1 		$89K Buy
3,906
+2,340
+149% +$41.9K ﹤0.01% 5020
2021
Q4 		$36K Sell
1,566
-59
-4% -$2.37K ﹤0.01% 5246
2021
Q3 		$96K Sell
1,625
-44
-3% -$3.19K ﹤0.01% 4722
2021
Q2 		$153K Buy
+1,669
New +$223K ﹤0.01% 4496

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's HOOK Position: Q2 2022 in Review

D.E. Shaw & Co sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 3,906 shares — an estimated $89K sold.

D.E. Shaw & Co first reported a position in HOOK in Q2 2021 and held it in 4 quarters. The position peaked at $153K in Q2 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

  • D.E. Shaw & Co reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,906 HOOKIPA Pharma shares in Q2 2022, an estimated $89K.
  • D.E. Shaw & Co first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's HOOKIPA Pharma position peaked at $153K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.